Manolagas S C
Division of Endocrinology & Metabolism, University of Arkansas for Medical Sciences, Little Rock 72205, USA.
Endocr Rev. 2000 Apr;21(2):115-37. doi: 10.1210/edrv.21.2.0395.
The adult skeleton regenerates by temporary cellular structures that comprise teams of juxtaposed osteoclasts and osteoblasts and replace periodically old bone with new. A considerable body of evidence accumulated during the last decade has shown that the rate of genesis of these two highly specialized cell types, as well as the prevalence of their apoptosis, is essential for the maintenance of bone homeostasis; and that common metabolic bone disorders such as osteoporosis result largely from a derangement in the birth or death of these cells. The purpose of this article is 3-fold: 1) to review the role and the molecular mechanism of action of regulatory molecules, such as cytokines and hormones, in osteoclast and osteoblast birth and apoptosis; 2) to review the evidence for the contribution of changes in bone cell birth or death to the pathogenesis of the most common forms of osteoporosis; and 3) to highlight the implications of bone cell birth and death for a better understanding of the mechanism of action and efficacy of present and future pharmacotherapeutic agents for osteoporosis.
成体骨骼通过临时细胞结构进行再生,这些结构由并列的破骨细胞和成骨细胞组成,并定期用新骨替换旧骨。过去十年积累的大量证据表明,这两种高度特化细胞类型的生成速率及其凋亡发生率对于维持骨稳态至关重要;而且,诸如骨质疏松症等常见的代谢性骨病很大程度上是由这些细胞的生成或死亡紊乱所致。本文的目的有三个:1)综述细胞因子和激素等调节分子在破骨细胞和成骨细胞生成及凋亡中的作用和分子作用机制;2)综述骨细胞生成或死亡变化对最常见骨质疏松症发病机制的影响证据;3)强调骨细胞生成和死亡对于更好理解当前及未来骨质疏松症药物治疗剂的作用机制和疗效的意义。